Infection in the newborn.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001724:Birth Weight; D000013:Congenital Abnormalities / Q000209:etiology; D003428:Cross Infection / Q000517:prevention & control; D003586:Cytomegalovirus Infections / Q000150:complications / Q000517:prevention & control; D005260:Female; D005315:Fetal Diseases / Q000209:etiology; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D007239:Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000150:complications; D012409:Rubella / Q000150:complications / Q000517:prevention & control; D014765:Viral Vaccines; D005719:gamma-Globulins
D000900:Anti-Bacterial Agents; D014765:Viral Vaccines; D005719:gamma-Globulins